Archive by category | Odds and ends

Lasker Awards go to rapid neurotransmitter release and modern cochlear implant

Lasker Awards go to rapid neurotransmitter release and modern cochlear implant

A very brainy area of research has scooped up one of this year’s $250,000 Lasker prizes, announced today: The Albert Lasker Basic Medical Research Award has gone to two researchers who shed light on the molecular mechanisms behind the rapid release of neurotransmitters—findings that have implications for understanding the biology of mental illnesses such as schizophrenia, as well the cellular functions underlying learning and memory formation.  Read more

Researchers less willing to share study details, according to journal’s survey

Researchers are increasingly reluctant to share the background details of their studies with other scientists according to new results from a survey of authors who published papers in the Annals of Internal Medicine in the last five years. This downward trend in researchers’ willingness to disclose such information is, unfortunately, at odds with the current surge in efforts to facilitate access to the types of study specifics that are vital to reproducing results.  Read more

Yale immunologist wins new €4 million award

Yale immunologist wins new €4 million award

Most scientists will say that they go to the lab every day out of a pure love of science, not to make buckets of money. But for researchers at the pinnacle of their fields, science can be a lucrative trade. Win a Nobel Prize, and you could take home more than $1.2 million. Bag a Templeton Prize, and you could be depositing a $1.7 million check. Net a Breakthrough Prize in Life Sciences, first awarded earlier this year, and you’d walk away with a cool $3 million.  Read more

Red blood cell production relies on white blood cell help

Red blood cell production relies on white blood cell help

Red blood cell production in the bone marrow is a precarious process. Too few RBCs and you can become anemic; too many and you could be suffering from polycythemia vera, a rare, so-called ‘myeloproliferative’ genetic disorder marked by an abnormally high RBC count. Now, researchers have identified a surprising player in the regulation of RBC production under these disease conditions. Reporting online today in Nature Medicine, two independent teams describe the pivotal role of macrophages—amoeba-like white blood cells responsible for digesting harmful foreign microbes and removing old or dying cells—for generating RBCs in both anemic and over-proliferative conditions.  Read more

Insurance challenges may lie ahead for New York labs hit by hurricane

Insurance challenges may lie ahead for New York labs hit by hurricane

At the end of turbulent week, the extent of the damage caused by Hurricane Sandy on biomedical research in the Northeast remains unclear, particularly at New York University’s Smilow Research Center, which flooded during the storm. The most devastating loss at the labs there may be the death of thousands of genetically modified mice and rats, and these animals represent the culmination of many years of research and thousands of dollars in funding. Although the cages the rodents lived in may be insured, it’s likely impossible to recoup the money and time spent to engineer the animals themselves. Biomedical scientists may not think about the insurance needs for their labs on a daily basis, and as some Nature Medicine spoke with, it’s not always easy to get experiments up and running even when insurance is in place.  Read more